Search
Searching Content indexed under Food, Drugs, Healthcare, Life Sciences by Bereskin & Parr LLP ordered by Published Date Descending.
Links to Result pages
 
1 2 3 4 5 6 7  
>>Next
 
Title
Country
Organisation
Author
Date
1
Canadian Drug Price Review Of Generic Companies Holding Patents
Generic drug companies typically do not have patents. Occasionally they may have patents on a new formulation of an old drug.
Canada
8 Oct 2019
2
While Americans Laud "Low" Canadian Drug Prices, Canadian Innovative Pharma Waits To See If The Pricing Axe Will Fall On "Excessive" Canadian Drug Prices
Whether a Canadian drug price is a bargain or excessive may depend on which side of the border you view it from. In the U.S.
Canada
9 Aug 2019
3
Balancing Efficiency And Compressed Timelines: Two Years Into The Amended Patented Medicines (Notice Of Compliance) Regulations
The September 21, 2017 amendments to the PMNOC Regulations brought significant change to litigation involving patented medicines in Canada
Canada
6 Aug 2019
4
Overview Of Canadian Patented Medicine Price Review
Companies launching patented medicines in Canada should be prepared for price review.
Canada
2 Aug 2019
5
What's In A Name? Biosimilar Nonproprietary Names
The U.S. federal government created a specially-designed, abbreviated biosimilar approval pathway
Canada
27 Jun 2019
6
Canadian Provincial Governments Actively Redirecting Patients To Biosimilar Drugs To Save Money
Biologics are drugs which contain an active medicinal ingredient that is derived from living cells.
Canada
11 Jun 2019
7
Cannabis Litigation Update: United Cannabis Corp v Pure Hemp Collective Inc.
Last September, before the new world of legalized recreational cannabis had opened-up in Canada, we reported on the state of IP litigation in the cannabis industry.
Canada
15 May 2019
9
Double Trouble: Avoiding Pitfalls In Canadian Pharmaceutical Patent Practice
Over the past several years, the environment for pharmaceutical patents in Canada has improved significantly.
Canada
5 Apr 2019
10
Patent Protection For Stem Cells - Expanding Opportunities
Therapeutic applications of stem cells are central to the promise of regenerative medicine. An increasing number of stem cell therapies are being approved for clinical use and by some estimates
Canada
28 Mar 2019
11
The Intersection Between Trademarks And Labelling Laws: An Illustration In The Cannabis Industry In Canada
Some of these prohibitions seem clear, such as that relating to the display of characters or animals.
Canada
12 Mar 2019
12
Small Claims Court Grants Trademark Relief — Seems Kosher
The recent small claims court decision in Kashruth Council of Canada v 1412189 Ontario Inc., 2018 CanLII 130064 saw the Ontario Small Claims Court grant the maximum $25,000 award available in that court to the plaintiff...
Canada
15 Feb 2019
13
2018 Year In Review: Life Sciences
2018 was another significant year for intellectual property in Canada with numerous court decisions and legislative changes.
Canada
7 Feb 2019
14
High Time To Protect Cannabis IP
After decades of global prohibition, cannabis in 2018 is rapidly going main­stream.
Canada
22 Jan 2019
15
Flying High - Recreational Cannabis Now Legal In Canada
Bill C-45, colloquially, the "Cannabis Act" (the "Act") came into force on October 17, 2018 legalizing recreational marijuana consumption ...
Canada
8 Nov 2018
16
Cannabis – From Mystery To Medical IP
Cannabis still maintains much of its mystery, thousands of years after it was first used by humans. There is great uncertainty among modern medical practitioners ...
Canada
23 Oct 2018
17
Drug Patent Term Restoration In Canada: Certificates Of Supplementary Protection
Like other patents in Canada, drug patents have a term limited to twenty years from the filing date.
Canada
17 Oct 2018
18
IP Litigation In The Cannabis Industry: A Review Of The Limited Authority In Canada Thus Far
As the day draws near to the legalization of recreational cannabis in Canada, so too does the birth of a new and significant industry.
Canada
1 Oct 2018
19
Broad Institute Prevails In Recent Round Of The US CRISPR Patent Battle
Control of intellectual property covering the CRISPR/Cas9 (CRISPR) gene editing system continues to be hotly contested.
United States
1 Oct 2018
20
Growing Your Cannabis IP Rights
Novel cannabis varieties may be protected in certain countries under various regimes.
Canada
25 Sep 2018
Links to Result pages
 
1 2 3 4 5 6 7  
>>Next